In general, the crucial role of DNAM-1 and NKG2D receptor-ligand interactions in NK cell-mediated killing of tumor cells is also observed in earlier reports on pediatric solid tumors and others tumors such as ovarian carcinoma, melanoma and acute myeloid leukemia [13, 17–23]. This evidence concerns the gene CD226 and acute myeloid leukemia.